(FRAG (NP (NN Purpose)) (: :) (S (NP (NP (DT The) (NN goal)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBZ is) (S (VP (TO to) (VP (VB show) (NP (NP (DT the) (NN advantage)) (PP (IN of) (NP (NP (DT a) (JJ collaborative) (NN work)) (PP (IN in) (NP (DT the) (ADJP (NP (NP (NN annotation) (CC and) (NN evaluation)) (PP (IN of) (NP (NP (NN prostate) (NN cancer) (NNS tissues)) (PP (IN from) (NP (NN T2)))))) (HYPH -) (VBN weighted)) (NN MRI)))))) (PP (VBN compared) (PP (IN to) (NP (DT the) (ADJP (RB commonly) (VBN used)) (JJ double) (JJ blind) (NN evaluation))))))))) (. .))
(FRAG (NP (NNS Methods)) (: :) (S (NP (NP (DT The) (NN variability)) (PP (IN of) (NP (JJ medical) (NNS findings)))) (VP (VBD focused) (PP (IN on) (NP (DT the) (NN prostate) (NN gland) (PRN (-LRB- -LRB-) (NP (NP (JJ central) (NN gland)) (, ,) (NP (ADJP (JJ peripheral) (CC and) (JJ tumoural)) (NNS zones))) (-RRB- -RRB-)))) (PP (IN by) (NP (NP (CD two) (JJ independent) (NNS experts)) (SBAR (S (VP (VBD was) (ADVP (RB firstly)) (VP (VP (VBN evaluated)) (, ,) (CC and) (ADVP (RB secondly)) (VP (VBN compared) (PP (IN with) (NP (NP (DT a) (NN consensus)) (PP (IN of) (NP (DT these) (CD two) (NNS experts)))))))))))))) (. .))
(S (S (VP (VBG Using) (NP (DT a) (NN prostate) (NN MRI) (NN database)))) (, ,) (NP (NNS experts)) (VP (VBD drew) (NP (NP (NNS regions)) (PP (IN of) (NP (NP (NP (NN interest)) (-LRB- -LRB-) (NP (NNS ROIs)) (-RRB- -RRB-)) (VP (VBG corresponding) (PP (IN to) (NP (NP (NP (JJ healthy) (NN prostate)) (-LRB- -LRB-) (NP (ADJP (JJ peripheral) (CC and) (JJ central)) (NNS zones)) (-RRB- -RRB-)) (CC and) (NP (NP (NN cancer)) (VP (VBG using) (NP (DT a) (JJ semi-automated) (NN tool))))))))))) (. .))
(S (NP (NP (CD One)) (PP (IN of) (NP (DT the) (NNS experts)))) (ADVP (RB then)) (VP (VBD drew) (NP (DT the) (NN ROI)) (PP (IN with) (NP (NP (NN knowledge)) (PP (IN of) (NP (NP (DT the) (JJ other) (NN expert) (POS 's)) (NN ROI)))))) (. .))
(S (NP (NP (NP (NNS Results)) (: :) (NP (NP (DT The) (NN surface) (NN area)) (PP (IN of) (NP (NP (DT each) (NN ROI)) (PP (IN as) (NP (DT the) (NNP Hausdorff) (NN distance))))))) (CC and) (NP (NP (DT the) (NN Dice) (NN coefficient)) (PP (IN for) (NP (DT each) (NN contour))))) (VP (VBD were) (VP (VBN evaluated) (PP (IN between) (NP (DT the) (JJ different) (NNS experiments))) (, ,) (S (VP (VBG taking) (NP (NP (DT the) (NN drawing)) (PP (IN of) (NP (NP (DT the) (JJ second) (NN expert)) (PP (IN as) (NP (DT the) (NN reference)))))))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (JJ significant) (NNS differences)) (PP (IN between) (NP (DT the) (CD two) (NNS experts)))) (VP (VBD became) (ADJP (JJ non-significant)) (PP (IN with) (NP (DT a) (JJ collaborative) (NN work))))))) (. .))
(FRAG (NP (NNS Conclusions)) (: :) (S (NP (DT This) (NN study)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (JJ collaborative) (NN work)) (PP (IN with) (NP (DT a) (JJ dedicated) (NN tool)))) (VP (VBZ allows) (NP (NP (DT a) (JJR better) (NN consensus)) (PP (IN between) (NP (NN expertise)))) (PP (IN than) (S (VP (VBG using) (NP (DT a) (JJ double) (JJ blind) (NN evaluation)))))))))) (. .))
(S (SBAR (IN Although) (S (NP (PRP we)) (VP (VBP show) (NP (NP (DT this)) (PP (IN for) (NP (ADJP (NP (NP (NN prostate) (NN cancer) (NN evaluation)) (PP (IN in) (NP (NN T2)))) (HYPH -) (VBN weighted)) (NN MRI))))))) (, ,) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (DT this) (NN research)))) (VP (MD can) (VP (VB be) (VP (VBN extrapolated) (PP (IN to) (NP (NP (JJ other) (NNS diseases) (CC and) (NN kind)) (PP (IN of) (NP (JJ medical) (NNS images)))))))) (. .))
